Baseline serum metabolomic profiles may help predict gout flare risk at ULT initiation and identify patients less likely to respond adequately to colchicine prophylaxis.

The FDA granted Priority Review to the supplemental BLA (sBLA) for efgartigimod alfa-fcab for the treatment of adults with acetylcholine receptor antibody (AChR-Ab) seronegative generalized myasthenia ...

Kinesio taping for musculoskeletal disorders may reduce pain intensity in the immediate and short term, but the evidence is uncertain.

Treatment with upadacitinib is safe and effective for adults and adolescents with nonsegmental vitiligo, according to a recent study.

Transcutaneous electrical nerve stimulation plus outpatient physical therapy reduces movement-based pain in patients with fibromyalgia.

Early and sustained adherence to antimalarials may help prevent RA and SLE disease flares, cardiovascular complications, and reduce future hospital use and costs.

Ixekizumab plus tirzepatide shows significant benefits for outcomes in psoriatic arthritis vs IXE alone in adults with overweight or obesity.

A multivariate risk score may help identify factors associated with sequelae and improve risk stratification in hematogenous spinal osteomyelitis.

Small improvements across the combination of sleep, physical activity, and nutrition may significantly reduce the risk for major adverse CV events.

Tumor necrosis factor inhibitors may offer mental health benefits in the management of patients with ankylosing spondylitis.

Glucagon-like peptide-1 receptor agonist use is associated with delayed wound healing in patients undergoing abdominal panniculectomy.

The global burden of RA is projected to rise through 2040 among women of childbearing age, especially in low- and middle-income areas.